The Future of Chronic Lymphocytic Leukaemia Treatment: Balancing Efficacy, Safety and Cost

Speakers:

Valentin Goede,¹ Clemens Wendtner,² George Follows³

1. Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
2. Chief Physician, Schwabing Hospital, Munich, Germany
3. Consultant Haematologist, Addenbrooke’s Hospital, Cambridge, UK

Acknowledgements:

Writing assistance has been provided by Trilogy Writing and Consulting Ltd.

Support:

This article has been supported financially by an educational grant from Mundipharma, who have had no editorial input.

Citation:

EMJ Oncol. 2013;1[1]:38-47. DOI/10.33590/emjoncol/10313452. https://doi.org/10.33590/emjoncol/10313452.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.